Joubert syndrome

Joubert syndrome is a rare autosomal recessive genetic disorder that affects the cerebellum, an area of the brain that controls balance and coordination.

Joubert syndrome
Other namesCPD IV[1]
Joubert syndrome is inherited via an autosomal recessive manner
SpecialtyMedical genetics Edit this on Wikidata

Joubert syndrome is one of the many genetic syndromes associated with syndromic retinitis pigmentosa.[2] The syndrome was first identified in 1969 by pediatric neurologist Marie Joubert in Montreal, Quebec, Canada, while working at the Montreal Neurological Institute and McGill University.[3]

Signs and symptoms

Most of the signs and symptoms of the Joubert syndrome appear very early in infancy with most children showing delays in gross motor milestones.[4] Although other signs and symptoms vary widely from individual to individual, they generally fall under the hallmark of cerebellum involvement or in this case, lack thereof. Consequently, the most common features include ataxia (lack of muscle control), hyperpnea (abnormal breathing patterns), sleep apnea, abnormal eye and tongue movements, and hypotonia in early childhood. Other malformations such as polydactyly (extra fingers and toes), cleft lip or palate, tongue abnormalities, and seizures may also occur. Developmental delays, including cognitive, are always present to some degree.[5] Severe forms have been noted to include hypoplasia of the corpus callosum.[6][7][8]

Those with this syndrome often exhibit specific facial features such as a broad forehead, arched eyebrows, ptosis (droopy eyelids), hypertelorism (widely spaced eyes), low-set ears and a triangle shaped mouth. Additionally, this disease can include a broad range of other abnormalities to other organ systems such as retinal dystrophy, kidney diseases, liver diseases, skeletal deformities and endocrine (hormonal) problems.[9]

Genetics

A number of mutations have been identified in individuals with Joubert syndrome (JBTS) which allowed for classification of the disorder into subtypes.[10]

This disorder can be caused by mutations in more than 30 genes within genetic makeup. The primary cilia play an important role in the structure and function of cells. When primary cilia are mutated and defected, it can cause various genetic disorders among individuals. This mutation of primary cilia can disrupt significant signaling pathways during the development of the fetus.[11]

Mutations in these various genes are known for causing around 60-90% of Joubert Syndrome cases. In the remaining cases, the cause is unknown if not linked to a mutation of known genes.[12]

Type OMIM Gene Locus Inheritance Remarks
JBTS1 213300 INPP5E 9q34.3 Autosomal recessive Also known as Cerebellooculorenal syndrome 1 (CORS1)
JBTS2 608091 TMEM216 11q12.2 Autosomal recessive Also known as Cerebellooculorenal syndrome 2 (CORS2)
JBTS3 608629 AHI1 6q23.3 Autosomal recessive
JBTS4 609583 NPHP1 2q13
JBTS5 610188 CEP290
NPHP6		 12q21.32 Autosomal recessive
JBTS6 610688 TMEM67 8q22.1 Autosomal recessive
JBTS7 611560 RPGRIP1L 16q12.2
JBTS8 612291 ARL13B 3q11.1
JBTS9 612285 CC2D2A 4p15.32 Autosomal recessive
JBTS10 300804 OFD1 Xp22.2 X-linked recessive
JBTS11 – TTC21B 2q24.3
JBTS12 – KIF7 15q26.1 Overlapping phenotype with acrocallosal syndrome[13]
JBTS13 614173 TCTN1 12q24.11
JBTS14 614424 TMEM237 2q33.1 Autosomal recessive
JBTS15 614464 CEP41 7q32.2 Autosomal recessive
JBTS16 614465 TMEM138 11q12.2 Autosomal recessive
JBTS17 614615 C5ORF42 5p13.2
JBTS18 614815 TCTN3 10q24.1
JBTS19 – ZNF423 16q12.1 Autosomal dominant
JBTS20 614970 TMEM231 16q23.1 Autosomal recessive
611654 CSPP1,[14][15][16] 8q13.2 Autosomal recessive
- ARMC9 2q37.1 Autosomal recessive
FAM149B1 10q22.2 Autosomal recessive

Diagnosis
(A) MRI Brain, axial T2 sequence showing enlarged superior cerebellar peduncles and vermian hypoplasia resulting in characteristic "molar tooth" appearance; (B) MRI Brain, sagittal T2 (a) and T1 (b) sequences showing vermian hypoplasia, predominantly at the superior aspect.

The disorder is characterized by absence or underdevelopment of the cerebellar vermis and a malformed brain stem (molar tooth sign), both of which can be visualized on a transverse view of head MRI scan.[17] Together with this sign, the diagnosis is based on the physical symptoms and genetic testing for mutations. If the gene mutations have been identified in a family member, prenatal or carrier diagnosis can be pursued.[4]

Joubert Syndrome is known to affect 1 in 80,000-100,000 newborns. Due to the variety of genes this disorder involves, it is likely to be under-diagnosed. It is commonly found in Ashkenazi Jewish, French-Canadians, and Hutterite ethnic populations. Most cases of Joubert syndrome are autosomal recessive; in these cases, both parents are either carriers or affected. Rarely, Joubert syndrome is inherited in an X-linked recessive pattern. In these cases, males are more commonly affected because they must have one X chromosome mutated, while affected females must have mutated genes on both X chromosomes.[12]

Treatment

Treatment for Joubert syndrome is symptomatic and supportive. Infants with abnormal breathing patterns should be monitored. The syndrome is associated with progressive worsening for kidneys, the liver and the eyes and thus requires regular monitoring.[5]

Delays in gross motor skills, fine motor skills and speech development are seen in almost all individuals with Joubert syndrome. Delays can be due to low muscle tone as well as impaired motor coordination. Some children have also been noted to have visual impairment due to abnormal eye movements. Developmental delays are usually treated with physical therapy, occupational therapy, and speech therapy interventions. Most children diagnosed with Joubert syndrome are able to achieve standard milestones, although often at a much later age.[18]

Prognosis

In a sample of 19 children, a 1997 study found that 3 died before the age of 3, and 2 never learned to walk. The children had various levels of delayed development with developmental quotients from 60 to 85.[19]

Research

Research has revealed that a number of genetic disorders, not previously thought to be related, may indeed be related as to their root cause. Joubert syndrome is one such disease. It is a member of an emerging class of diseases called ciliopathies.[20]

The underlying cause of the ciliopathies may be a dysfunctional molecular mechanism in the primary cilia structures of the cell, organelles which are present in many cellular types throughout the human body. The cilia defects adversely affect "numerous critical developmental signaling pathways" essential to cellular development and thus offer a plausible hypothesis for the often multi-symptom nature of a large set of syndromes and diseases.

Currently recognized ciliopathies include Joubert syndrome, primary ciliary dyskinesia (also known as Kartagener Syndrome), Bardet–Biedl syndrome, polycystic kidney disease and polycystic liver disease, nephronophthisis, Alström syndrome, Meckel–Gruber syndrome and some forms of retinal degeneration.[21]

Joubert syndrome type 2 is disproportionately frequent among people of Jewish descent.[22]

References
  1. "Orphanet: Joubert syndrome". www.orpha.net. Retrieved 24 October 2019.
  2. Saraiva JM, Baraitser M (July 1992). "Joubert syndrome: a review". American Journal of Medical Genetics. 43 (4): 726–31. doi:10.1002/ajmg.1320430415. PMID 1341417.
  3. Joubert M, Eisenring JJ, Robb JP, Andermann F (September 1969). "Familial agenesis of the cerebellar vermis. A syndrome of episodic hyperpnea, abnormal eye movements, ataxia, and retardation". Neurology. 19 (9): 813–25. doi:10.1212/wnl.19.9.813. PMID 5816874.
  4. "Joubert Syndrome - NORD (National Organization for Rare Disorders)". NORD (National Organization for Rare Disorders). Retrieved 2016-12-19.
  5. Parisi MA, Doherty D, Chance PF, Glass IA (May 2007). "Joubert syndrome (and related disorders) (OMIM 213300)". European Journal of Human Genetics. 15 (5): 511–21. doi:10.1038/sj.ejhg.5201648. PMID 17377524.
  6. "OMIM Entry - # 213300 - JOUBERT SYNDROME 1; JBTS1". www.omim.org. Retrieved 2019-12-22.
  7. Zamponi N, Rossi B, Messori A, Polonara G, Regnicolo L, Cardinali C (2002). "Joubert syndrome with associated corpus callosum agenesis". European Journal of Paediatric Neurology. 6 (1): 63–6. doi:10.1053/ejpn.2001.0542. PMID 11993957.
  8. Bader I, Decker E, Mayr JA, Lunzer V, Koch J, Boltshauser E, et al. (August 2016). "MKS1 mutations cause Joubert syndrome with agenesis of the corpus callosum". European Journal of Medical Genetics. 59 (8): 386–91. doi:10.1016/j.ejmg.2016.06.007. PMID 27377014.
  9. "Joubert syndrome". MedlinePlus Genetics. National Institutes of Health.
  10. Parisi, Melissa; Glass, Ian (1993), Adam, Margaret P.; Ardinger, Holly H.; Pagon, Roberta A.; Wallace, Stephanie E. (eds.), "Joubert Syndrome", GeneReviews®, Seattle (WA): University of Washington, Seattle, PMID 20301500, retrieved 2022-02-11
  11. Waters AM, Beales PL (July 2011). "Ciliopathies: an expanding disease spectrum". Pediatric Nephrology. 26 (7): 1039–56. doi:10.1007/s00467-010-1731-7. PMC 3098370. PMID 21210154.
  12. "Joubert syndrome". Genetics Home Reference. Retrieved 2017-09-13.
  13. Online Mendelian Inheritance in Man (OMIM): 200990
  14. Shaheen R, Shamseldin HE, Loucks CM, Seidahmed MZ, Ansari S, Ibrahim Khalil M, et al. (January 2014). "Mutations in CSPP1, encoding a core centrosomal protein, cause a range of ciliopathy phenotypes in humans". American Journal of Human Genetics. 94 (1): 73–9. doi:10.1016/j.ajhg.2013.11.010. PMC 3882732. PMID 24360803.
  15. Akizu N, Silhavy JL, Rosti RO, Scott E, Fenstermaker AG, Schroth J, et al. (January 2014). "Mutations in CSPP1 lead to classical Joubert syndrome". American Journal of Human Genetics. 94 (1): 80–6. doi:10.1016/j.ajhg.2013.11.015. PMC 3882909. PMID 24360807.
  16. Tuz K, Bachmann-Gagescu R, O'Day DR, Hua K, Isabella CR, Phelps IG, et al. (January 2014). "Mutations in CSPP1 cause primary cilia abnormalities and Joubert syndrome with or without Jeune asphyxiating thoracic dystrophy". American Journal of Human Genetics. 94 (1): 62–72. doi:10.1016/j.ajhg.2013.11.019. PMC 3882733. PMID 24360808.
  17. Brancati F, Dallapiccola B, Valente EM (July 2010). "Joubert Syndrome and related disorders". Orphanet Journal of Rare Diseases. 5: 20. doi:10.1186/1750-1172-5-20. PMC 2913941. PMID 20615230.
  18. "Joubert Syndrome | MedLink Neurology". www.medlink.com. Retrieved 3 April 2020.
  19. Steinlin M, Schmid M, Landau K, Boltshauser E (August 1997). "Follow-up in children with Joubert syndrome". Neuropediatrics. 28 (4): 204–11. doi:10.1055/s-2007-973701. PMID 9309710. S2CID 260241632.
  20. Sattar S, Gleeson JG (September 2011). "The ciliopathies in neuronal development: a clinical approach to investigation of Joubert syndrome and Joubert syndrome-related disorders". Developmental Medicine and Child Neurology. 53 (9): 793–798. doi:10.1111/j.1469-8749.2011.04021.x. PMC 3984879. PMID 21679365.
  21. Badano JL, Mitsuma N, Beales PL, Katsanis N (September 2006). "The ciliopathies: an emerging class of human genetic disorders". Annual Review of Genomics and Human Genetics. 7: 125–48. doi:10.1146/annurev.genom.7.080505.115610. PMID 16722803.
  22. Gutkind L, Kennedy P (10 October 2013). An Immense New Power to Heal: The Promise of Personalized Medicine. Underland Press. p. 36. ISBN 978-1-937163-07-5.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.